Latest News

Date Title Topic
11 Dec 2017 ESMO Immuno Oncology Congress 2017: Webcasts
11 Dec 2017 MMR Deficiency Screening is Under-utilised in Young Adult Patients with Colorectal Cancer Gastrointestinal cancers - Cancer in Special Situations
Certificate of Attendance
08 Dec 2017 ESMO IO 2017 Press Release: Novel Compound Restores Immune Response In Patients With Melanoma Melanoma and other skin tumours - Cancer Immunology and Immunotherapy
08 Dec 2017 ESMO IO 2017 Press Release: Researchers Discover Resistance Mechanism To Checkpoint Inhibitors And How To Reverse It Cancer Immunology and Immunotherapy
07 Dec 2017 ESMO Factsheet on Biomarker: PD-L1
07 Dec 2017 Current Status and Future Outlook in Cancer Immunotherapy
07 Dec 2017 ESMO IO 2017 Press Release: First Line Combination Therapy Improves Progression-Free Survival In Advanced Lung Cancer Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
06 Dec 2017 FDA Approves Ogivri as a Biosimilar to Herceptin Breast cancer - Anticancer agents & Biologic therapy
05 Dec 2017 EMA Issues Warning About Use of Radium-223 Dichloride in Combination With Abiraterone Acetate and Prednisone or Prednisolone Genitourinary cancers - Anticancer agents & Biologic therapy
04 Dec 2017 FDA Grants Marketing Approval to FoundationOne CDx In Vitro Diagnostic Personalised medicine
01 Dec 2017 New Translations of the ESMO Patient Guide in NSCLC Now Available
29 Nov 2017 New EU Guidelines on Good Manufacturing Practices for Advanced Therapies Bioethics, legal and economic issues
28 Nov 2017 New EMA CHMP Guideline on the Evaluation of Anticancer Medicinal Products in Man Anticancer agents & Biologic therapy